Home›Search›Urologic Oncology: Seminars and Original Investigations

Urologic Oncology: Seminars and Original Investigations

Elsevier Inc. · United States

ISSN1078-1439eISSN1873-2496

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.997

H-Indexi

107

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.793

Total Worksi

7,404

Total Citationsi

114,289

2yr Mean Citednessi

1.09

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Urologic Oncology: Seminars and Original Investigations publishes clinical and basic science research articles that address any aspect of urologic oncology. It is the official journal of the Society of Urologic Oncology.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

FrequencyEight Issues A Year, 2013-

StatusActive

Total Publications7,404

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Publishing ModelHybrid

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

⚡ Hybrid journal — subscription model available.

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Elsevier Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1078-1439 / 1873-2496

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

301

4.9k

2019

427

5.6k

2020

360

4.2k

2021

287

2.4k

2022

256

1.5k

2023

581

1.2k

2024

613

534

2025

172

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

UrologyQ1

OncologyQ2

Subject Classification

Web of Science Categories

OncologyUrology & Nephrology

Scopus Categories

UrologyOncology

Research Topics (OpenAlex)

Bladder and Urothelial Cancer TreatmentsProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentUrinary and Genital Oncology StudiesRenal cell carcinoma treatment

Frequently asked questions about Urologic Oncology: Seminars and Original Investigations

Is Urologic Oncology: Seminars and Original Investigations a predatory journal?

PubScope has no integrity flags on record for Urologic Oncology: Seminars and Original Investigations: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Urologic Oncology: Seminars and Original Investigations?

Urologic Oncology: Seminars and Original Investigations is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.09.

Is Urologic Oncology: Seminars and Original Investigations indexed in Scopus and Web of Science?

Urologic Oncology: Seminars and Original Investigations is indexed in Web of Science, Scopus.